Don't Give Up

There is a “can” in cancer because we can beat it. Cancer is a disease which involves abnormal cell growth with the potential to invade or spread to other parts of the body. If a cell is severely damaged and cannot repair itself, it undergoes a so-called programmed cell death or apoptosis. Cancer occurs when damaged cells grow, divide, and spread abnormally instead of self-destructing as they should.

CyberKnife is one of PAF’s most remarkable achievements since its inception. CyberKnife is a robotic, cutting-edge technology that uses a high cancer-killing dose of radiation in a precise, painless, and non-invasive manner. It is an effective alternative to surgery, treating not just tumors anywhere in the body, but other medical disorders like trigeminal neuralgia and AV malformations as well. There is no risk of infection, hemorrhage or healthy tissue injury during the time of the procedure.

Patients’ aid foundation (PAF) helped bring this whole body stereo-tactic radio surgery facility to JPMC, making it the first and only such facility in the nation. The treatment costs around $50,000 – $90,000 per patient internationally, but with PAF’s help, free cancer treatment is available at JPMC for underprivileged people. Cyberknife treats hard tissue cancers and is the best alternative for cancer treatment. Potential benefits of the CyberKnife system include:
  • No incision
  • No pain
  • No anesthesia or hospitalization
  • Greater comfort (patient can breathe normally during treatment)
  • Little or no recovery time
  • Immediate return to normal activities
PAF’s motto is to turn tears into cheers, therefore, they have established a medical center which is associated with JPMC; it is the only medical center in the world that is providing the CyberKnife treatment absolutely free for the needy. They are supporting the fighters, admiring the survivors, honoring the taken and never ever giving up the hope. For more information and detail visit their website
Don't Give Up Don't Give Up Reviewed by Pakistan Aid Foundation on March 19, 2018 Rating: 5

No comments:

Powered by Blogger.